A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG

Published 2008 View Full Article

Authors

Keywords

Journal

INFECTION AND IMMUNITY

Volume 76, Issue 11, Pages 5200-5214

Publisher

American Society for Microbiology

Online

2008-08-26

DOI

10.1128/iai.00434-08

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

INFECTION AND IMMUNITY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Find the ideal target journal for your manuscript